# Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in Adults

> **NCT07002060** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 640 (actual)

## Conditions studied

- Yellow Fever Immunization

## Interventions

- **BIOLOGICAL:** Yellow fever vaccine (live)
- **BIOLOGICAL:** YF vaccine (live)

## Key facts

- **NCT ID:** NCT07002060
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-05-22
- **Primary completion:** 2026-01-20
- **Final completion:** 2026-01-20
- **Target enrollment:** 640 (ACTUAL)
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07002060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07002060, "Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in Adults". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07002060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*